INVO Fertility, Inc. Common Stock

INVO Fertility trades with a microscopic market cap below $10 million, making it a micro-cap penny stock with virtually no institutional liquidity—a setup ripe for wild swings. The 7.62% short interest isn't trivial for a company this small, and with RSI at 51.4 showing neither overbought nor oversold conditions, the technical picture offers no safety guardrails. The absence of a P/E ratio signals either deep unprofitability or insufficient earnings to calculate valuation metrics, which is typical for pre-revenue or heavily money-losing biotech hardware plays. This combination—micro-cap status, meaningful short exposure, and fundamental valuation opacity—creates potential squeeze risk alongside severe execution risk on the core fertility technology business.